The epidemiology of hepatocellular carcinoma

European Journal of Gastroenterology and Hepatology

Volumn 8, Issue 9, 1996, Pages 845-849

  Johnson, Philip J ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Aflotoxin; Cirrhosis; Hepatitis B; Hepatitis C; Hepatocellular carcinoma

Indexed keywords

AFLATOXIN; HEPATITIS B VACCINE; ORAL CONTRACEPTIVE AGENT; THORIUM DIOXIDE;

CHRONIC HEPATITIS; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS C; HUMAN; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY;

AFLATOXINS; CARCINOMA, HEPATOCELLULAR; CONTRACEPTIVES, ORAL; DEMOGRAPHY; HEPATITIS B; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; RISK FACTORS; THORIUM DIOXIDE;

EID: 0029767661     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (50)

1. Parkin DM: Cancer Occurrence in Developing Countries (IARC Scientific Publications no. 75). Lyon: International Agency for Research on Cancer; 1986.
2. Waterhouse JAH, Muir C, Shanmugaratnam K, Powell J: Cancer Incidence in Five Continents (IARC Scientific Publications no. 42), vol 5. Lyon: International Agency for Research on Cancer; 1982.
3. The Editorial Committee for the Atlas of Cancer Mortality in the People's Republic of China. Atlas of Cancer Mortality in the People's Republic of China. China Map Press.
4. Beasley RP: Hepatitis B virus the major etiology of hepatocellular carcinoma. Cancer 1988, 60:1942.
5. Blumberg BS, Alter HJ, Visnich S: A 'new' antigen in leukaemia sera. JAMA 1965, 191:541.
6. Bosch FX, Munoz N: Epidemiology of hepatocellular carcinoma. In Neoplasms of the Liver. Edited by Okuda K, Ishak KG. Tokyo: Springer-Verlag; 1987:3-20.
7. Beasley RP. Hepatitis B virus. The major aetiology of hepatocellular carcinoma. In Accomplishment in Cancer Research. Edited by Fortner JC, Rhoads JE. Philadelphia: JB Lippincott; 1988:80-106.
8. Seeff LB, Beebe GW, Hoofnagle J, Norman JE, Buskell-Bales Z, Waggoner JG, et al.: A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. N Engl J Med 1987, 316:965-970.
9. Beebe GW, Norman JE: Study of the likelihood of hepatocellular carcinoma following the 1942 US Army epidemic of hepatitis B. In Etiology, Pathology and Treatment of Hepatocellular Carcinoma in North America. Edited by Tabor E, Di Bisceglie AM, Purcell RH. Houston: Gulf Publishing Company; 1991:3-15.
10. Tong MJ, Schwindt RR, Lo G-H, Co RL: Chronic hepatitis and hepatocellular carcinoma in Asian Americans. In Etiology, Pathology and Treatment of Hepatocellular Carcinoma in North America. Edited by Tabor E, Di Bisceglie AM, Purcell RH. Houston: Gulf Publishing Company; 1991:16-25.
11. Zaman SN, Johnson PJ, Williams R: Hepatocellular carcinoma in immigrants to the United Kingdom. QJM 1986, 232:813-817.
12. Kiyosawa K, Akaesane Y, Nagata A, Furuta S: Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitis. Am J Gastroenterol 1984, 79:777-781.
13. Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sanchez-Tapias JM, et al.: Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989, ii:1004-1006.
14. Chiaramonte M, Farinati F, Fagiuoli S, Ongaro S, Aneloni V, De Maria N, et al.: Antibody to hepatitis C in hepatocellular carcinoma. Lancet 1990, i:301-304.
15. Colombo M, Kuo G, Choo QL, Donato MF, Del Ninno E, Tommasini MA, et al.: Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989, ii:1006-1008.
16. Nappas B, Dias. F, Pol S, Hamelin B, Housset C, Brecht C, et al.: Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease. J Hepatol 1991, 12:70-74.
17. Zara G, Mavelka J, Joller-Jemelka HJ, Garson SA, Rists B, Meer B, et al.: Hepatitis C virus (HCV) and hepatocellular carcinoma (HCC). J Hepatol 1991, 13:S183.
18. Lam KC, Yu MC, Leung JWC, Henderson BE: Hepatitis B virus and cigarette smoking: risk factors for hepatocellular carcinoma in Hong Kong. Cancer Res 1987, 42:5246-5248.
19. Austin H, Delzell E, Grufferman S, Levine R, Morrison AS, Stolley PD, et al.: A case-control study of hepatocellular carcinoma and the hepatitis B virus, cigarette smoking and alcohol consumption. Cancer Res 1986, 46:962-966.
20. Johnson PJ, Williams R: Hepatitis C antibodies and hepatocellular carcinoma. New clues or a false trail? J Natl Cancer Inst 1990, 82:986-987.
21. McFarlane IG, Smith H, Johnson PJ, Bray G, Vergani D, Williams R: Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false positive result? Lancet 1990, i:754-757.
22. Lenzi M, Johnson PJ, McFarlane IG, Ballardini G, Smith HM, McFarlane BM, et al.: Autoimmune liver disease and antibodies to HCF: evidence for geographical heterogeneity using a new synthetic peptide-based assay. Lancet 1991, 338:277-280.
23. Ohkose S, Kato N, Kinoshita T, Hijikata M, Ohtsuyama Y, Okazaki N, et al.: Detection of hepatitis C virus RNA in sera and liver tissues of non-A, non-B hepatitis patients using the polymerase chain reaction, Japan J Cancer Res 1990, 81:862.
24. Shibata M, Takeda S, Kudo T, Kimura H, Kukushima K, Morishima T, et al.: Minus strand RNA of hepatitis C virus in liver tissues. J Hepatol 1991, 13:379.
25. Ruiz J, Cuende JI, Sangro B, Herrero JI, Belogni O, Prieto J: Hepatitis C virus (HCV) viraemia in patients with hepatocellular carcinoma (HCC) detected by nested PCR. J Hepatol 1991, 13: S165.
26. Colombo M, Mannucci PM, Brettler DB, Girolami A, Lian EC, Rodeghiero F, et al.: Hepatocellular carcinoma in hemophilia. Am J Hematol 1991, 37:243-246.
27. Simonetti RG, Camma C, Fiorella F, Cottone M, Rapicetta M, Marino L, et al.: Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. Ann Intern Med 1992, 116:97-102.
28. Naumov NV, Chokshi S, Metivier E, Maertens G, Johnson PJ, Williams R: HCV replication is an important factor for hepatocellular carcinoma development in patients with cirrhosis. Hepatology 1994, 20:285a.
29. Caparoso N, Romano M, Marmo R, di Sio I, Morisco F, Minerva A, et al.: Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis. J Hepatol 1991, 12:367-372.
30. Peers FG, Linsell CA: Dietary aflatoxins and liver cancer. A population based study in Kenya. Br J Cancer 1973, 27:473-484.
31. Peers FG, Gilman GA, Linsell CA: Dietary aflatoxins and human liver cancer. A study in Swaziland, Int J Cancer 1976, 17:167-176.
32. Peers FG, Bosch X, Kaldore J, Linsell A, Pluijmen M: Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland, Int J Cancer 1987, 39:545-553.
33. Ross RK, Yuan JM, Yu MC, Wogan GN, Qian C-S, Tu J-T, et al: Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992, 339:943-946.
34. Quin GS, Ross RK, Yu MC, Yuan JM, Goa YT, Henderson BE, et al.: A follow-up study or urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, Peoples Republic of China. Cancer Epidemiol Biomarkers Prev 1994, 3:3-10.
35. Columbo M, De Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, et al.: Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991, 325:675.
36. Johnson PJ, Williams R: Cirrhosis and the aetiology of hepatocellular carcinoma. J Hepatol 1987, 4:140-147.
37. Zaman SN, Johnson PJ, Williams R: Silent cirrhosis in patients with hepatocellular carcinoma: implications for screening in high and low incidence areas. Cancer 1990, 63:1607-1610.
38. Zaman SN, Melia WM, Johnson RD, Johnson PJ, Williams R: Risk factors for the development of hepatocellular carcinoma in cirrhosis. A prospective study of 613 patients. Lancet 1985, i:1357-1360.
39. Villa E, Melegari M, Scaglioni PP, Trande P, Cesaro P, Menenti F: Hepatocellular carcinoma: risk factors other than HBV. Ital J Gastroenterol 1991, 23:457.
40. Nappas B, Diss F, Pol S, Hamelin B, Housset C, Brecht C, et al.: Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease. Hepatology 1990. 12:70-74.
41. Bode JC, Bermann J, Kohse KP, Walker S, Bode C: High incidence of antibodies to hepatitis C virus in alcoholic cirrhosis: fact or fiction? Alcohol Alcoholism 1991, 11:26-30.
42. Walter E, Blum HE, Meer P, Huonker M, Schmid M, Maer K-P, et al.: Hepatocellular carcinoma in alcoholic liver disease: no evidence for a pathogenic role of hepatitis B virus infection. Hepatology 1988, 8:745-750.
43. The German Thorotrast Study. Edited by van Kaick G, Muth H, Kaul A. Commission of the European Communities, 1984.
44. Van Kaick G, Muth H, Kaul A, Immich H, Lebermann D, Lorenz D, et al.: Results of the German Thorotrast study. In Radiation Carcinogenesis Epidemiology and Biological Significance. Edited by Boice JD Jr, Fraumeni IF Jr. New York: Raven Press; 1984:253-262.
45. Jick H, Herman R: Oral contraceptives induced benign liver tumours. The magnitude of the problem. JAMA 1978, 240:828-829.
46. Henderson BE, Preston-Martin S, Edmondson HA, Peters RL, Pike MC: Hepatocellular carcinoma and oral contraceptives. Br J Cancer 1983, 48:437-440.
47. Neuberger J, Forman D, Doll R, Williams R: Oral contraceptives and hepatocellular carcinoma. BMJ 1986, 292:1355-1357.
48. Forman D, Doll R, Peto R: Trends in mortality from carcinoma of the liver and the use of oral contraceptives. Br J Cancer 1983, 48:349-354.
49. Forman D, Vincent TJ, Doll R: Cancer of the liver and the use of oral contraceptives. BMJ 1986, 292:1357-1361.
50. Johnson PJ: Why can't we cure liver cancer? [invited editorial] Eur J Cancer 1995, 31a:1562-1564.